What's breaking now, across thousands of outlets.
The FDA approved Roivant’s dermatomyositis drug brepocitinib on Wednesday, the first major regulatory nod that could usher in a multibillion revenue stream for the hub-and-spoke pharma. The drug, marketed as Lisraya, is the first oral ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The widow of a man who died with a rare neurodegenerative disease says the Northern Territory's new voluntary assisted dying laws are "very weak" and will fail many who need them.
Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely used for heart failure, work by activating a key enzyme that helps heart cells…
Dr. Laura Cox joins Norah O'Donnell on "Healthful" to debunk myths about certain foods and their potential impact on your gut microbiome.
(MedPage Today) -- At 71 and a few years into retirement, Linda Henry felt like she was in good health, and only went to her doctor in Southern California for the occasional checkup.
